Status:
COMPLETED
The Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator
Lead Sponsor:
University Health Network, Toronto
Conditions:
The Study Focuses on the Effect of a New Supraglottic Airway With Built-in Cuff Pressure Indicator on Postoperative Pharyngolaryngeal Adverse Events
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The study compares the incidence of pharyngolaryngeal complications in patients managed with either a pressure-limiting strategy using the AES Ultra CPVTM or a standard practice using a LMA, in ambula...
Detailed Description
Recent evidence suggests that reduction of LMA intracuff pressure may decrease the incidence of pharyngolaryngeal symptoms. Yet, pressure manometers are not widely available limiting the application o...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists physical status I-III
- 18 to 65 years of age
- Ambulatory patients scheduled to undergo knee arthroscopy, transurethral resection of bladder tumor, hand, gynecological, general surgical and eye procedures under a short general anesthesia of less than 2 hours
- Spontaneously breathing on the LMA
Exclusion
- Reduced mouth opening less than 2.5cm
- Recent history of upper respiratory tract infection and sore throats
- Contraindications of LMA use (Morbid obesity with body mass index greater than 40kg/m2, symptomatic hiatus hernia, esophageal reflux disease)
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT01800344
Start Date
January 1 2012
End Date
October 1 2012
Last Update
February 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy Health Network- Toronto Western Hospital
Toronto, Ontario, Canada, M5T2S8